Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms.
about
Cerebrospinal Fluid Particles in Alzheimer Disease and Parkinson DiseaseApolipoprotein E and Alzheimer disease: risk, mechanisms and therapyIdentification of a Chrysanthemic Ester as an Apolipoprotein E Inducer in AstrocytesPreferential interactions between ApoE-containing lipoproteins and Aβ revealed by a detection method that combines size exclusion chromatography with non-reducing gel-shiftIn vivo human apolipoprotein E isoform fractional turnover rates in the CNSApolipoprotein E isoform-specific effects on lipoprotein receptor processing.Retinoic acid isomers facilitate apolipoprotein E production and lipidation in astrocytes through the retinoid X receptor/retinoic acid receptor pathway.The role of apolipoprotein E in Alzheimer's disease.Multiple SNPs within and surrounding the apolipoprotein E gene influence cerebrospinal fluid apolipoprotein E protein levels.A-Subclass ATP-Binding Cassette Proteins in Brain Lipid Homeostasis and Neurodegeneration.ABC Transporters and the Alzheimer's Disease Enigma.Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer's diseaseDevelopment and evaluation of a multiplexed mass spectrometry based assay for measuring candidate peptide biomarkers in Alzheimer's Disease Neuroimaging Initiative (ADNI) CSF.Neurodegeneration and Alzheimer's disease (AD). What Can Proteomics Tell Us About the Alzheimer's Brain?Abca1 deficiency affects Alzheimer's disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice.Role of ATP-binding cassette transporters in brain lipid transport and neurological disease.The role of ATP-binding cassette transporter A1 in Alzheimer's disease and neurodegenerationResearch Lumbar Punctures among African Americans and Caucasians: Perception Predicts Experience.Peripheral apoE isoform levels in cognitively normal APOE ε3/ε4 individuals are associated with regional gray matter volume and cerebral glucose metabolism.CSF Apo-E levels associate with cognitive decline and MRI changesSoluble apoE/Aβ complex: mechanism and therapeutic target for APOE4-induced AD risk.ApoE and Aβ in Alzheimer's disease: accidental encounters or partners?Apolipoprotein E, amyloid-beta, and neuroinflammation in Alzheimer's diseaseATP-binding cassette transporter A1: from metabolism to neurodegeneration.Effects of ABCA1 R219K Polymorphism and Serum Lipid Profiles on Mild Cognitive Impairment in Type 2 Diabetes Mellitus.Central Nervous System Lipoproteins: ApoE and Regulation of Cholesterol Metabolism.Cerebrospinal fluid apolipoprotein E concentration and severity of cognitive impairment in patients with newly diagnosed Alzheimer's disease.Lipid Nanoparticle Delivery of siRNA to Silence Neuronal Gene Expression in the BrainAmyloid-β42 alters apolipoprotein E solubility in brains of mice with five familial AD mutations.The serine protease HtrA1 contributes to the formation of an extracellular 25-kDa apolipoprotein E fragment that stimulates neuritogenesis.Apolipoprotein E levels in the cerebrospinal fluid of north Indian patients with Alzheimer's disease.Quantitative assessment of the effect of ABCA1 gene polymorphism on the risk of Alzheimer's disease.
P2860
Q27314618-D45C5A08-9D6A-4707-AE1B-E464E8222CF8Q28282855-38D527ED-67F9-4510-84B2-CFF95BA5202FQ28553918-263B36AD-C893-4389-91C9-5217EFAC5679Q28582464-CF254173-EA37-483F-8C2C-D53BA05E9991Q28728902-33BB4E66-DC23-4055-B228-370FB9337A3AQ33112703-BA0FEF44-B10C-4D48-A1F7-9A246D382435Q33676328-24DE8B9A-D717-4D7D-A544-2DFD69E28B18Q34603092-1EBCA5AD-D12E-4CEB-B707-B22D377953D6Q35337926-8A5C6A47-2AC6-4B1B-9183-8E5D5C301EEEQ35801008-7A340A4D-8AA3-4C64-ADCD-C911C68A77BDQ36005085-F8A70302-D57D-4D34-82D6-BBD4E6FBE9E6Q36283394-C24F28EE-8A00-49E5-9362-D8EE2CF432DDQ36539376-273158A9-CCF3-4E66-8A8F-C88E52AE192EQ36539454-68DA346B-D721-47BB-9E0C-5B8D3DE69EC1Q36822983-89532810-1AB5-4925-995D-EFAEE4A1FFC2Q36987318-3259ED1D-BA3D-4B4E-9F8F-41BCE75E2C81Q37017266-34C60746-586A-4B48-A0B4-A83E27CCF647Q37463657-3ACDED2D-5555-4D3F-8B3E-4C0A1580E230Q37615967-521AF9B5-9040-4AFF-88D4-50FB8DA48F90Q37705204-6C46F19C-6F3B-4B2A-B67E-ACC81A71D59FQ38175420-11B3159A-BC6F-4EDD-A0E5-5B009D5749A2Q38190156-82F46101-7DD4-4C4D-A201-E9D26E042B2BQ38197948-58526D2D-B2A9-422C-B210-C436D35F370BQ38213077-3528C632-3930-4902-86C2-9027BAB87B06Q38616803-8C5D2261-A330-47AF-9937-2BD2DCDC0A84Q38833309-CE08241B-27D5-42DE-8AB5-48540FDF694AQ39307470-9AC136D5-DF87-43DE-8CD0-3FDBDDB4446FQ41810449-E297896C-60C8-416C-96D9-851C3FE5C6D8Q42651770-C74118C9-A4B6-405C-AB67-EA5F72CA0255Q50134122-C671E332-E173-479C-9179-61FB2C5C5043Q51047459-56CA67D6-5596-415E-8CE2-16131C950674Q53334126-8B7F4C54-AA25-472B-8DA1-5A0DFBF306DA
P2860
Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms.
@ast
Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms.
@en
type
label
Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms.
@ast
Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms.
@en
prefLabel
Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms.
@ast
Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms.
@en
P2093
P2860
P50
P356
P1476
Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms.
@en
P2093
Aarti R Shah
Andrew Grupe
Anthony Hinrichs
Hong Jiang
John S K Kauwe
Kevin Mayo
Leon J Thal
Scott Smemo
Suzanne E Wahrle
P2860
P2888
P356
10.1186/1750-1326-2-7
P577
2007-04-12T00:00:00Z
P5875
P6179
1018463350